FDA & Prescription Drugs

• Statins Increases Diabetes Risk in Older Women

  Shezad Malik MD JD | January 09, 2012 8:04 PM | 0 CommentsFort Worth, TX

  Analysis of data from the Women's Health Initiative, postmenopausal women who were on a statin at study entry had almost a 50% greater risk of diabetes than those who weren't on the...

• FDA Undertakes Safety Review of Pradaxa...What This Means To You

  Pete Flowers | January 09, 2012 2:55 PM | 0 CommentsWindy City, IL

  Dabigatran (Pradaxa) is a blood thinner known as a direct thrombin inhibitor that was approved to reduce the risk of stroke and blood clots in patients with non-valvular atrial...

• YAZ Settlement News Philly Mass Tort Court Orders Mediation

  Shezad Malik MD JD | January 08, 2012 11:33 AM | 0 CommentsFort Worth, TX

  Following the lead of the Federal Court ordered mediation in the Yaz/Yasmin litigation, the Pennsylvania state court judge has entered a similar order. Judge Moss, who is managing...

• Shortage of Prescription Drugs Serious Problem for Patients

  David Mittleman | January 08, 2012 10:00 AM | 0 CommentsLansing, MI

  Doctors, patients, and pharmacists have cited increasing concerns over the shortage of some important prescription drugs such as Adderall and life saving cancer medications. As a result, patients...

• Actos Bladder Cancer Lawsuits

  Michael Monheit | January 06, 2012 12:07 PM | 1 CommentCentral Pennsylvania, PA

  Type 2 Diabetes patients prescribed Actos for long-term treatment are starting to flood into the court system with claims that Actos caused them to develop bladder cancer. In June of 2011,...

• Lights Out for Bayer's YAZ?

  Shezad Malik MD JD | January 06, 2012 9:38 AM | 0 CommentsFort Worth, TX

  Bayer AG, Germany’s largest drugmaker, blinked and swallowed hard, at the end of December, when it begged the Court overseeing the YAZ litigation. Bayer managed to avoid the first trial...

• Novartis Tekturna Problems Study Cancellation

  Shezad Malik MD JD | January 05, 2012 9:35 PM | 0 CommentsFort Worth, TX

  Medical side effect concerns about Tekturna, a blood pressure drug sold by Novartis, have arisen after clinical trials were canceled due to a high number of strokes and kidney problems among...

• Yaz Lawsuits Move Toward Mediation Settlement Possibility

  Brett Emison | January 04, 2012 10:21 AM | 0 CommentsKansas City, MO

  United States District Court Judge David R. Herndon moved parties in Yaz, Yasmin and Ocella lawsuits toward settlement through court-ordered mediation in an order entered New Year's Eve -...

• First Yaz Injury Trial Ordered to Mediation

  Shezad Malik MD JD | January 03, 2012 12:19 PM | 0 CommentsFort Worth, TX

  YAZ Settlement Ordered The federal judge overseeing the thousands of Yaz, Yasmin and Ocella venous thrombo-embolism lawsuits, has delayed the first trial scheduled to begin January 9th. The...

• Actos Bladder Cancer Cases Centralized In Western Louisiana

  Shezad Malik MD JD | January 02, 2012 7:57 PM | 1 CommentFort Worth, TX

  The Judicial Panel on Multidistrict Litigation (JPML) is streamlining litigation for all federal cases alleging injury caused by the diabetes drug ACTOS®. These cases will now be brought...